<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1232</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15448365</PubmedId>
            <Abstract>A CD8+ T-cell memory response to respiratory syncytial virus (RSV) was generated by using a DNA vaccine construct encoding the dominant Kd-restricted epitope from the viral transcription anti-terminator protein M2 (M2(82-90)), linked covalently to human beta2-microglobulin (beta2m). Cutaneous gene-gun immunization of BALB/c mice with this construct induced an antigen-specific CD8+ T-cell memory. After intranasal RSV challenge, accelerated CD8+ T-cell responses were observed in pulmonary lymph nodes and virus clearance from the lungs was enhanced. The construct induced weaker CD8+ T-cell responses than those elicited with recombinant vaccinia virus expressing the complete RSV M2 protein, but stronger than those induced by a similar DNA construct without the beta2m gene. DNA vaccination led to enhanced pulmonary disease after RSV challenge, with increased weight loss and cell recruitment to the lung. Depletion of CD8+ T cells reduced, but did not abolish, enhancement of disease. Mice vaccinated with a construct encoding a class I-restricted lymphocytic choriomeningitis virus epitope and beta2m suffered more severe weight loss after RSV infection than unvaccinated RSV-infected mice, although RSV-specific CD8+ T-cell responses were not induced. Thus, in addition to specific CD8+ T cell-mediated immunopathology, gene-gun DNA vaccination causes non-specific enhancement of RSV disease without affecting virus clearance.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>3017-3026</ArticlePages>
            <ArticleTitle>Gene-gun DNA vaccination aggravates respiratory syncytial virus-induced pneumonitis.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Bartholdy</LastName>
                    <ForeName>Christina</ForeName>
                </Author>
                <Author>
                    <LastName>Olszewska</LastName>
                    <ForeName>Wieslawa</ForeName>
                </Author>
                <Author>
                    <LastName>Stryhn</LastName>
                    <ForeName>Anette</ForeName>
                </Author>
                <Author>
                    <LastName>Thomsen</LastName>
                    <ForeName>Allan Randrup</ForeName>
                </Author>
                <Author>
                    <LastName>Openshaw</LastName>
                    <ForeName>Peter J M</ForeName>
                </Author>
            </Authors>
            <Affiliations>Institute of Medical Microbiology and Immunology, University of Copenhagen, Copenhagen, Denmark; Department of Respiratory Medicine, Imperial College, St Mary's Campus, Norfolk Place, Paddington, London W2 1PG, UK.</Affiliations>
            <ArticleChemicalList>Epitopes, T-Lymphocyte;Respiratory Syncytial Virus Vaccines;Vaccines, DNA;Viral Proteins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Biolistics; CD8-Positive T-Lymphocytes(immunology); CpG Islands; Epitopes, T-Lymphocyte; Female; Immunologic Memory; Mice; Mice, Inbred BALB C; Pneumonia, Viral(etiology; immunology); Respiratory Syncytial Virus Infections(immunology); Respiratory Syncytial Virus Vaccines(immunology); Vaccination; Vaccines, DNA(immunology); Viral Proteins(genetics; immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>85</Volume>
                <Issue>Pt 10</Issue>
                <Title>The Journal of general virology</Title>
                <Issn>0022-1317</Issn>
                <MedlineTa>J Gen Virol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>M2 82-90</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SYIGSINNI</LinearSequence>
                        <StartingPosition>82</StartingPosition>
                        <EndingPosition>90</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P04545.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11259</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Aurhors' communication</LocationOfData>
                <EpitopeId>62576</EpitopeId>
                <ReferenceStartingPosition>82</ReferenceStartingPosition>
                <ReferenceEndingPosition>90</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <TCellId>18365</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SYIGSINNI</LinearSequence>
                                            <StartingPosition>82</StartingPosition>
                                            <EndingPosition>90</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P04545.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11259</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <RecombinantOrganism>
                                        <SubType>Recombinant Organism</SubType>
                                        <RecombinantOrganismId>10245</RecombinantOrganismId>
                                    </RecombinantOrganism>
                                </ImmunogenContainingObject>
                                <Route>Scarification</Route>
                                <DoseSchedule>1 dose of 3x10^6 pfu</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>PECs were isolated 3 wks after the immunization.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>Unknown/Unspecified</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>169</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>M2 82-90</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SYIGSINNI</LinearSequence>
                                        <StartingPosition>82</StartingPosition>
                                        <EndingPosition>90</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P04545.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11259</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>5</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Significant levels (6-16%) of IFN-g+ CD8+ CD44 high cells are seen in peptide stimulated PECs from mice immunized with a recombinant vaccinia vector encoding the epitope. DNA vaccines encoding the epitope induce lower levels of IFN-g production.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <TCellId>18342</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SYIGSINNI</LinearSequence>
                                            <StartingPosition>82</StartingPosition>
                                            <EndingPosition>90</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P04545.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11259</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>M2Beta2m (M2 82-90-linker-Beta2microglobulin)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 doses of 1 microgram of DNA coated gold particles 3 weeks apart</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>PECs were isolated 3 wks after the last immunization. .</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>Unknown/Unspecified</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>169</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>M2 82-90</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SYIGSINNI</LinearSequence>
                                        <StartingPosition>82</StartingPosition>
                                        <EndingPosition>90</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P04545.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11259</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>5</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Significant levels (2-5%) of IFN-g+ CD8+ CD44 high cells are detected in peptide stimulated PECs from DNA vaccinated animals encoding epitope linked to human beta2-microglobulin, but not when a DNA vaccine encodes the epitope alone. The level of IFN-g production is lower than in PECs from mice immunized with a recombinant vaccinia vector encoding the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 4 and 5</LocationOfData>
                        <TCellId>18767</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo to prevent or reduce disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SYIGSINNI</LinearSequence>
                                            <StartingPosition>82</StartingPosition>
                                            <EndingPosition>90</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P04545.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11259</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>M2Beta2m (M2 82-90-linker-Beta2microglobulin)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 doses of 1 microgram of DNA coated gold particles 3 weeks apart</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>I.n. infection with 10&lt;sup&gt;6&lt;/sup&gt; PFU RSV 3 wk after the last immunization.</ImmunizationComments>
                        </Immunization>
                        <AntigenPresentingCells>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11259</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>182</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Viral loads in the lungs are lower in B2m-linker-epitope vaccinated than in empty plasmid vaccinated animals 4 days after virus challenge, implying partial resistance to infection in vaccinated animals, not seen when DNA vaccine encodes the epitope alone. The level of reduction is lower than in mice immunized with a recombinant vaccinia vector encoding the epitope. The effect of vaccination, known in other RSV vaccines to aggravate the severity of symptoms (in this case, weight loss, hunched posture and ruffled fur) is seen to occur also with this vaccine and in DNA or recombinant vaccinia (encoding epitope alone) vaccinated animals. The effect is not totally abolished by anti-CD8+ mAb administration. Analysis of the cell infiltrate in lungs revealed a lymphocyte and PMN infiltration above the levels seen in non-vaccinated animals.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <TCellId>18363</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SYIGSINNI</LinearSequence>
                                            <StartingPosition>82</StartingPosition>
                                            <EndingPosition>90</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P04545.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11259</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 doses of 1 microgram DNA coated gold particles, administered 3 weeks apart</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>PECs were isolated 3 wks after the last immunization.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>Unknown/Unspecified</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>169</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>M2 82-90</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SYIGSINNI</LinearSequence>
                                        <StartingPosition>82</StartingPosition>
                                        <EndingPosition>90</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P04545.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11259</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>IFN-g+ CD8+ CD44 high cells are undetectable after peptide stimulation of PECs from DNA vaccinated animals encoding epitope. IFN-g production is seen by PECs from mice immunized with a construct encoding the epitope as a fusion peptide with human B2 microglubulin and also with a recombinant vaccinia vector encoding the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>18367</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SYIGSINNI</LinearSequence>
                                            <StartingPosition>82</StartingPosition>
                                            <EndingPosition>90</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P04545.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11259</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>M2Beta2m (M2 82-90-linker-Beta2microglobulin)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 doses of 1 microgram of DNA coated gold particles 3 weeks apart</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>I.n. infection with 10&lt;sup&gt;6&lt;/sup&gt; PFU RSV 3 wk or 3 mo after the last immunization, and SIN were harvested 4 or 7 days later.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Lymph Node</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymph Node</CellTissueType>
                            <CellType>Unknown/Unspecified</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>169</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>M2 82-90</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SYIGSINNI</LinearSequence>
                                        <StartingPosition>82</StartingPosition>
                                        <EndingPosition>90</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P04545.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11259</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The IFN-g+ CD8+ CD44 high epitope specific population is higher in the B2m-linker-epitope DNA immunized animals than in animals immunized with epitope alone at 4 days after infection, even when the infection is administered up to 3 months post vaccination, but are not significantly different at day 7 post infection.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

